ABBV

2024Q1BMO

AbbVie Inc primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2024-04-26 · Fiscal end 2024-03-31 · Features as of 2024-04-25

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS2.23
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move1.5%
IV front—
P/C full—
P/C front—
Features as of2024-04-25

Run-up

Close—
Ret 5d+1.6%
Ret 10d-0.1%
Ret 20d-7.2%
Ret 30d-7.0%

Post-Earnings Data

Results & reaction

Print

Actual EPS
2.31Beat
Estimated EPS2.23
Actual revenue
12.3B
Surprise %+3.6%
Beat / missBeat
Beat streak 44
Beat streak 84

Reaction

1-day stock reaction-4.5%
Implied vs actual

Implied 1.5%Actual 0.1%

Gap reaction-0.1%
Day result-4.6%
Next-day upNo
Realized / IV0.08×

Post tape

Post 5d+2.6%
Post 10d+0.7%
Post volume10.7M
Vol ×10d2.09×
Vol ×20d2.04×
Post range5.9%